Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$37,500.00
Dec 19, 2025
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
1038025
The Project will support development of intellectual property capacity within the Firm.
$152,600.00
Jul 14, 2025
For-profit organization
MIGS Implantation Testing
1032736
The project is intended to evaluate the pre-clinical safety and performance of the Hexiris MIGS device through the use of a long-term (6-month) implantation study.
$75,000.00
Jun 3, 2024
For-profit organization
Verification on MIGS
1019421
Complete prototype validation of innovative MIGS (Minimally Invasive Glaucoma Surgery) devices which will enable bringing glaucoma surgery from the operating room to outpatient clinics. By the end of October 2024, Hexiris will have conducted successful testing of the Functional MIGS on both animal and human cadaveric eyes, demonstrating its efficacy and safety for progression to animal and human clinical trials.
$19,862.58
Jun 1, 2024
For-profit organization
Hexiris Inc.-2024-2025-1024988
1024988
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$4,075.00
Mar 8, 2023
Not-for-profit organization or charity
CIIP PDA – Name of the Vendor – 2022-23
7448714 P012600001
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$30,000.00
Nov 14, 2022
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
998018
The Project will support development of intellectual property capacity within the Firm
$75,000.00
Nov 7, 2022
For-profit organization
Minimally Invasive Bleb-Forming Punch
997106
Presenting early-stage glaucoma patients with a minimally invasive approach to lower intraocular pressure with a bleb-forming procedure as an alternative to traditional trabeculectomy or tube surgery. Minimally Invasive Bleb-Forming Punch (MIBP) uses a new, creative injector punch to drain the liquid out of the eye. The punch removes tissue creating a tunnel to allow the eye to drain without the need for an implant. This next generation glaucoma surgery is targeted to early-stage patients as an outpatient procedure. Although the MIBS devices depend on creating an external filtering bleb, they are associated with fewer risks than traditional glaucoma surgeries, offering a favorable safety profile procedure with faster recovery.
$75,000.00
Oct 17, 2022
For-profit organization
Implant Stability and Performance Studies
996212
The next generation of implant and delivery system for ab-external minimally invasive glaucoma surgery (MIGS) which will enable bringing glaucoma surgery from the operating room to outpatient clinics.
$50,000.00
Nov 1, 2021
For-profit organization
Feasibility of Implant Device
980891
The firm is advancing development of their prototyped device for minimally invasive glaucoma surgery. This game changer device will make the treatment of glaucoma safer, more accessible and cost-effective. This project will take the current prototype design and develop it into a final prototype ready for animal testing.